RT
Rupinder Tewari
About Rupinder Tewari
Data last updated:
Rupinder Tewari is a Director at Nectar Life Sciences Limited (since 2019), Director at Nectar Life Sciences Limited (since 2019) and Director at Nureca Limited (since 2025). The companies operate in Pharma and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹3,472 Cr; the largest is Nectar Life Sciences Limited at ₹1,675 Cr (FY 2025). Earlier, Rupinder Tewari was a Director at Venus Remedies Limited (2014–2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 11 Feb 2019 | 1995 | ₹1,675 Cr (FY 2025) | Active | |
| Director | 11 Feb 2019 | 1995 | ₹1,675 Cr (FY 2025) | Active | |
| Director | 01 Jan 2025 | 2016 | ₹122 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Dec 2014 | 1989 | ₹669 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rupinder Tewari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Indu Pal Kaur | 09686862 | Nectar Life Sciences Limited , Nectar Life Sciences Limited | Director |
| Kuldip Kumar Bhasin | 09250008 | Nectar Life Sciences Limited , Nectar Life Sciences Limited and 1 more | Director |
| Sanjaymohan Singh Rawat | Nectar Life Sciences Limited , Nectar Life Sciences Limited | Company Secretary | |
| Sanjiv Goyal | 00002841 | Nectar Life Sciences Limited , Nectar Life Sciences Limited | Managing Director |
| Surulichamy Senthilkumar | 11124083 | Nectar Life Sciences Limited , Nectar Life Sciences Limited | Director |
| Sushil Kapoor | 00063525 | Nectar Life Sciences Limited , Nectar Life Sciences Limited | Whole-Time Director |
| Chander Kant | Nureca Limited | Cfo | |
| Charu Singh | 07822158 | Nureca Limited | Director |
| Nishu Kansal | Nureca Limited | Company Secretary | |
| Rajinder Sharma | 00317133 | Nureca Limited | Whole-Time Director |
| Ruchita Agarwal | 08941249 | Nureca Limited | Director |
| Saurabh Goyal | 00136037 | Nureca Limited | Managing Director |
| Smita Goyal | 08929179 | Nureca Limited | Whole-Time Director |
| Vijay Kumar Sharma | 02449088 | Nureca Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rupinder Tewari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rupinder Tewari
Rupinder Tewari currently holds 3 directorships: Nectar Life Sciences Limited (Director, since 11 Feb 2019, revenue ₹1,675 Cr (FY 2025)); Nectar Life Sciences Limited (Director, since 11 Feb 2019, revenue ₹1,675 Cr (FY 2025)); Nureca Limited (Director, since 01 Jan 2025, revenue ₹122 Cr (FY 2025)).
Rupinder Tewari was first appointed on 30 Dec 2014 as Director at Venus Remedies Limited. The most recent appointment on record is 01 Jan 2025 at Nureca Limited.
The 3 current companies of Rupinder Tewari that report revenue have a combined latest revenue of ₹3,472 Cr: Nectar Life Sciences Limited ₹1,675 Cr (FY 2025); Nectar Life Sciences Limited ₹1,675 Cr (FY 2025); Nureca Limited ₹122 Cr (FY 2025).
Rupinder Tewari held 1 earlier board appointment: Venus Remedies Limited (Director, 30 Dec 2014 to 24 May 2019).
The current boards of Rupinder Tewari's companies include Indu Pal Kaur (Nectar Life Sciences Limited), Kuldip Kumar Bhasin (Nectar Life Sciences Limited), Sanjaymohan Singh Rawat (Nectar Life Sciences Limited), Sanjiv Goyal (Nectar Life Sciences Limited), Surulichamy Senthilkumar (Nectar Life Sciences Limited), Sushil Kapoor (Nectar Life Sciences Limited), among others.